("NetScientific" or the "Company" or the "Group")
Wanda Strengthens its Board with Digital Health Non-Executive Director
Derek Newell brings decades of digital health expertise
London, UK - 08 September 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that one of its portfolio companies, Wanda, has appointed a new Non-Executive Director, Derek Newell, to its Board.
Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific and Chairman of Wanda, said: "Derek is a highly regarded and knowledgeable industry leader with vast experience in the field of innovative health technology. We are delighted that Wanda has further strengthened its Board with a digital health expert of his calibre."
The full text of the announcement issued by Wanda on 07 September 2016 is as follows:
Wanda Appoints Jiff CEO Derek Newell an Outside Director
Newell brings decades of digital health expertise to the Wanda board
SAN FRANCISCO - 07 September, 2016 - Wanda™, recognized for bringing new and proven technologies to home-centered care, today announced the appointment of Derek Newell as an outside director. Newell is currently CEO of Jiff, a provider of an enterprise health benefits platform.
"Derek pioneered the use of remote patient monitoring technologies and will be an invaluable addition to the Wanda board," said Steve Curd, Wanda's CEO. "As we continue to enhance the Wanda offering, I am confident that Derek will offer tremendous insights and provide us with a unique perspective as we continue to advance our technical, operational, and financial objectives."
Newell brings 20 years of experience as a leader of innovative health technology and service companies. Prior to joining Jiff as CEO, Newell was president and CEO of Robert Bosch Healthcare and worked with the management team to build Bosch into the world's largest remote patient monitoring company. Before Bosch he was CEO of remote patient monitoring company Health Hero Networks, which sold to Bosch in 2007. Health Hero Network was the first company to get an internet connected medical device approved by the FDA. Newell also served as chief marketing officer of LifeMasters, where he helped pioneer the first patient-centric disease management platform and built one of the largest disease management companies in the US. Derek holds graduate degrees in business and public health from UC Berkeley.
"I'm deeply committed to advancing the development of innovative technologies that reduce the cost chronic disease and enhance the lives of individuals with chronic conditions," said Newell. "I am impressed with the potential of the Wanda platform to solve some of healthcare's toughest challenges, based on how elegantly it converges proven machine-learning analytics and behavioral science. Wanda's ability to deliver ongoing risk analysis and decision support is better equipping individuals to care for themselves and allowing clinicians to more efficiently engage with consumers who are in most need of their assistance."
- Ends -
For more information, please contact:
François R. Martelet, M.D., CEO
Ian Postlethwaite, CFO
Tel: +44 (0)20 3514 1800
Consilium Strategic Communications
Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton
Tel: +44 (0)20 3709 5700
About NetScientific Plc
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.
This information is provided by RNS